Disease Map

-
Disease map from Healthmap.org

Comments

Post a Comment

Popular posts from this blog

LICENSING PROCESS

-
The licensing plan First, you need to write down a specific plan. More specifically: 1. Develop a strategy. Will it be an exclusive or non-exclusive license? Will it be limited to various fields? Will it augment sales after your company launches the product? Will you be licensing a limited number licensees or staging them in? What incentives have you considered? 2. Do a SWOT analysis. This is a term used by licensing experts which means you need to analyze and evaluate your intellectual property’s Strengths, Weaknesses, Opportunities and Threats. This is important, because your licensees will do this and if you’re not prepared, you’ll not be able to handle their questions. With these two steps completed, you will want to start taking action. Next: 1. Find licensees. Use New Product Summaries and the methods discussed in the web pages on marketing inventions. 2. Research interested candidates. Once a candidate is identified, research it to better understand it. 3. Start with a term shee...
Read more

Building the Business Case for Innovation

-
Innovation has transitioned from a “nice to have” to a top priority for most companies because innovation drives organic growth. Like other business processes, innovation can be managed to achieve results. Unlike other business processes, innovation requires introducing risk, embracing failure, and doing things that are counter to most efficiency driving processes. Building a business case for innovation requires addressing these and other differences based on how innovation will be implemented within the organization. Specifying the approach, the impact on everyone in the organization, and the means by which innovation will occur in an organization drives the business case and increases the likelihood of success.... more
Read more

Suven Life Sciences Patents

-
Suven Life Sciences, a Hyderabad-based biopharmaceutical company specialising in central nervous system (CNS) diseases, got patent for the candidate (SUVN-502), achieved through internal discovery efforts of Suven, has been validated in all the nine member countries of Eurasia (including Russia) and 37 member countries of Europe including major markets like Germany, Switzerland, Denmark, Spain, France, UK, Italy, the Netherlands, Poland, Sweden and Finland Read More
Read more